Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,308 | 121 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $567.21 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $318.82 | 18 | $0 (2024) |
| Merz North America, Inc. | $253.75 | 2 | $0 (2022) |
| Kestra Medical Technology Services, Inc. | $169.21 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $108.97 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $108.45 | 6 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $101.95 | 6 | $0 (2024) |
| PFIZER INC. | $101.12 | 5 | $0 (2024) |
| Amgen Inc. | $100.40 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $71.09 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,016 | 59 | Novartis Pharmaceuticals Corporation ($283.29) |
| 2023 | $720.37 | 40 | Novartis Pharmaceuticals Corporation ($205.74) |
| 2022 | $571.58 | 22 | Merz North America, Inc. ($253.75) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $12.20 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Varithena_PI | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.53 | General |
| Category: Medical Device | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Cardiology | ||||||
| 10/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.07 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.82 | General |
| Category: Cardiology | ||||||
| 10/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $33.44 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/15/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: Medical Device | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,068 | 1,796 | $173,943 | $58,943 |
| 2022 | 13 | 1,411 | 2,243 | $273,971 | $94,219 |
| 2021 | 5 | 599 | 726 | $170,385 | $45,190 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 453 | 524 | $81,224 | $28,367 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 262 | $63,086 | $19,842 | 31.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 66 | 66 | $10,300 | $4,234 | 41.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,318 | $4,016 | 38.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 93 | 126 | $3,780 | $1,037 | 27.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 79 | 82 | $2,378 | $679.16 | 28.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 18 | 18 | $1,620 | $604.42 | 37.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 71 | 373 | $932.50 | $139.66 | 15.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 33 | 304 | $304.00 | $22.64 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 372 | 543 | $137,498 | $45,274 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 495 | 609 | $100,218 | $35,100 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 55 | 55 | $8,756 | $4,370 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $6,888 | $3,225 | 46.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 50 | $5,745 | $1,850 | 32.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 191 | 208 | $6,251 | $1,825 | 29.2% |
| 16020 | Dressing change or removal of burn tissue, less than 5% of total body surface | Office | 2022 | 17 | 22 | $3,850 | $1,260 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 78 | 94 | $2,820 | $888.15 | 31.5% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2022 | 11 | 11 | $825.00 | $248.49 | 30.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 45 | 239 | $597.50 | $95.15 | 15.9% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 26 | 65 | $162.50 | $32.71 | 20.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 36 | 297 | $297.00 | $28.50 | 9.6% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2022 | 11 | 21 | $63.00 | $22.27 | 35.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 330 | 413 | $77,644 | $25,808 | 33.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 138 | 173 | $46,018 | $15,372 | 33.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 17 | 17 | $41,650 | $2,340 | 5.6% |
About Ashley Davis, FNP
Ashley Davis, FNP is a Nurse Practitioner healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1396230504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Davis, FNP has received a total of $2,308 in payments from pharmaceutical and medical device companies, with $1,016 received in 2024. These payments were reported across 121 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,308).
As a Medicare-enrolled provider, Davis has provided services to 3,078 Medicare beneficiaries, totaling 4,765 services with total Medicare billing of $198,352. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Summerfield, FL
- Active Since 06/29/2018
- Last Updated 05/02/2025
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1396230504
Products in Payments
- LEQVIO (Drug) $473.17
- VERQUVO (Drug) $318.82
- Xeomin (Biological) $253.75
- Assure WCD (Device) $169.21
- ELIQUIS (Drug) $151.20
- XARELTO (Drug) $108.45
- LifeVest (Device) $101.95
- Repatha (Biological) $100.40
- ENTRESTO (Drug) $94.04
- BRILINTA (Drug) $93.21
- Kerendia (Drug) $65.12
- Inpefa (Drug) $40.84
- (CK4) MCOT (Device) $38.58
- NEXLETOL (Drug) $34.07
- WATCHMAN FLX (Device) $33.44
- JARDIANCE (Drug) $29.09
- INJECTAFER (Drug) $24.65
- Vascepa (Drug) $23.27
- PAXLOVID (Drug) $21.01
- Varithena Administration Pack (Device) $20.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Summerfield
Ms. Robyn Carlisle, Arnp-C, ARNP-C
Nurse Practitioner — Payments: $3,138
Ms. Melinda Rogers, Arnp, ARNP
Nurse Practitioner — Payments: $1,319
Kristen Teel, Pa-C, PA-C
Nurse Practitioner — Payments: $818.86
Amy Ester, Fnp-C, FNP-C
Nurse Practitioner — Payments: $97.85
Lauren Smith, Dnp, DNP
Nurse Practitioner